University of California San Francisco
Give to UCSF
Researchers at UC San Francisco have successfully developed a “speech neuroprosthesis” that has enabled a man with severe paralysis to communicate in sentences, translating signals from his brain to the vocal tract directly into words that appear as text on a screen.
Scientists at UCSF have shown that gene-edited cellular therapeutics can be used to successfully treat cardiovascular and pulmonary diseases in mice.
Taking a page from computer engineers, biologists are trying their hands at programming cells – by building DNA circuits to guide their protein-making machinery and behavior.
UCSF is launching a new initiative to propel the development of living therapeutics – a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease – and bring them quickly to patients.
The viruses that cause polio and COVID-19 mutate, but treatments for the diseases don’t. For over 20 years, UCSF and Gladstone Institutes scientist Leor Weinberger, PhD, has been thinking of ways to make vaccines work more efficiently by being adaptive, rather than static.
Leading scientists share some of the tools and strategies that could help us better confront and contain future outbreaks.
Under the agreement, Thermo Fisher will build and operate a 45,000-square-foot, state-of-the-art cell therapy development, manufacturing and collaboration center in leased space on UCSF’s Mission Bay campus.
A team at UCSF, in collaboration with colleagues at Stanford University, has unearthed the regulatory DNA sequences of our archaic human ancestors in a discovery that sheds light on how we diverged from them 500,000 years ago.
There is a big, global problem: viruses such as HIV and COVID-19 mutate, but treatments for them don’t.
UCSF gathered leading Bay Area scientists and clinicians to reflect on the scientific challenges and breakthroughs of the past year since COVID-19 was declared a pandemic.
Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy Grail of oncology research.
AAAS Fellowship recognizes important contributions to STEM disciplines, including pioneering research, leadership within a given field, teaching and mentoring, fostering collaborations, and advancing public understanding of science.
We asked a team of UCSF kidney experts – including nephrologist, a transplant surgeon, a transplant pharmacist and a bioengineer – to shine a light on the problem of kidney disease and share their hopes for the future.
Scientists at UCSF are exploring how we can improve our bodies – now and in the future – with science that sounds like sci-fi.
From international awards for high-caliber research to groundswell movements for social change, this past year was an eventful one for the UCSF community.
